
GLOW
Research peptide blend containing GHK-Cu, TB-500 and BPC-157. Supplied as a 70mg lyophilised vial for laboratory research workflows.
PayPal or cash on collection · UK 18+ verification at checkout · For laboratory research use only
Frequently bought together
Full catalogue →
MOTS‑C
Mitochondrial‑derived peptide. Studied in preclinical research on AMPK activation and metabolic‑regulation pathways.

GLP1‑TRIPLE (Reta)
Triple agonist (GLP‑1/GIP/glucagon receptor). Studied in preclinical metabolic research.

AOD 9604
Modified fragment of human growth hormone (hGH 176‑191). Studied in preclinical research examining lipid‑metabolism pathways.

ARA‑290
Non‑erythropoietic EPO analogue (cibinetide). Studied in preclinical research on innate‑repair‑receptor (IRR) signalling pathways.
Often stacked with GLOW
Full catalogue →
GHK‑Cu
Copper peptide naturally occurring in plasma. Studied in preclinical research on skin remodelling, wound‑repair pathways, and gene‑expression modulation. Referenced in cellular‑senescence research groupings.

TB‑500
Synthetic thymosin beta‑4 fragment. Studied in preclinical models examining wound‑repair and cell‑migration pathways. Frequently referenced alongside BPC‑157 in research.

BPC‑157
Gastric pentadecapeptide. Studied in preclinical models of tissue repair and gastrointestinal research.
